VANGUARD GROUP INC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 148 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$94,336,226
+3.2%
4,604,013
+0.1%
0.00%0.0%
Q2 2023$91,400,569
+17.7%
4,599,928
+1.5%
0.00%0.0%
Q1 2023$77,640,422
-5.2%
4,532,424
+8.3%
0.00%0.0%
Q4 2022$81,930,626
+50.2%
4,186,542
+22.5%
0.00%0.0%
Q3 2022$54,544,000
+18.1%
3,417,511
+1.8%
0.00%
+100.0%
Q2 2022$46,172,000
-13.1%
3,355,491
+0.2%
0.00%0.0%
Q1 2022$53,118,000
-26.3%
3,349,160
+1.5%
0.00%
-50.0%
Q4 2021$72,064,000
-25.7%
3,301,138
+1.7%
0.00%0.0%
Q3 2021$97,004,000
-31.7%
3,245,388
+1.2%
0.00%
-50.0%
Q2 2021$142,072,000
+10.0%
3,207,765
+10.2%
0.00%
+33.3%
Q1 2021$129,186,000
+15.6%
2,911,574
+42.9%
0.00%0.0%
Q4 2020$111,734,000
+154.8%
2,037,459
+6.2%
0.00%
+200.0%
Q3 2020$43,844,000
+8.6%
1,918,005
-0.5%
0.00%0.0%
Q2 2020$40,358,000
+55.8%
1,928,284
+3.8%
0.00%0.0%
Q1 2020$25,907,000
-36.7%
1,857,107
+3.3%
0.00%0.0%
Q4 2019$40,908,000
+126.7%
1,797,400
+16.1%
0.00%0.0%
Q3 2019$18,044,000
-19.9%
1,548,787
+3.1%
0.00%0.0%
Q2 2019$22,536,000
+1.4%
1,502,349
+18.6%
0.00%0.0%
Q1 2019$22,223,000
+31.9%
1,266,938
+11.4%
0.00%0.0%
Q4 2018$16,852,000
-28.8%
1,137,070
+18.3%
0.00%0.0%
Q3 2018$23,671,000
+42.0%
961,464
+13.2%
0.00%0.0%
Q2 2018$16,671,000
+31.9%
849,284
+26.0%
0.00%0.0%
Q1 2018$12,637,000674,0190.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$11,354,00010.44%
RTW INVESTMENTS, LP 15,802,802$250,632,0005.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 63,000$17,884,0004.03%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,077,0004.02%
Prosight Management, LP 203,268$3,224,0002.08%
COWEN AND COMPANY, LLC 1,000,000$15,860,0001.53%
Boxer Capital, LLC 1,466,051$23,252,0001.20%
Cormorant Asset Management, LP 868,550$13,775,0001.06%
Amitell Capital Pte Ltd 97,331$1,544,0000.90%
SECTORAL ASSET MANAGEMENT INC 303,975$4,821,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders